Home › NDC Lookup › Ingredients › Sulfur › 24286-1574-02
Acne Treatment with Sulfur 10 g/100g Ointment, 156 g — NDC 24286-1574-02 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Acne Treatment with Sulfur 10 g/100g Ointment, 156 g — NDC 24286-1574-2 (Billing 24286-1574-02)

by DLC Laboratories, Inc. · 156 g in 1 JAR

This is a package of 156 g of Acne Treatment with Sulfur 10 g/100g Ointment from DLC Laboratories, Inc., marketed since Aug 2019 and currently FDA-listed.

NDC 24286-1574-02
🏷️ FDA NDC (as labeled) 24286-1574-2 billing pads the package segment with a zero
This package
Contains156 g Pack sizes5 compare ↓
Product page 24286-1574-01 Also comes in: 2.8 g 24286-1574-5 6 g 24286-1574-4 74 g 24286-1574-1 73.7 g 24286-1574-3
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Aug 13, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 24286-1574-2
Product NDC 24286-1574
11-digit billing NDC 24286157402
RxCUI 313148
UNII 70FD1KFU70
UPC 0073472001639
Application # M006
SPL Set ID 4a1591e8-6135-4b22-b54c-5553c2dc0540
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2019-08-26
Route TOPICAL
Dosage form OINTMENT
Substance SULFUR
Quick answers
  • RxCUI (RxNorm): 313148
Why two NDCs? The FDA registers this code as 24286-1574-2 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 24286-1574-02. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Preparations containing sulfur class.

Drug family (ATC) Preparations containing sulfur
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

🧪 What is this product?

This is an over-the-counter ointment applied to the skin that contains sulfur as its active ingredient. Sulfur is commonly used in acne and skin care products to help reduce excess oil and address certain types of skin blemishes. This product is marketed under FDA's established rules for over-the-counter acne treatments rather than as an individually reviewed medication. The ointment form allows the sulfur to be spread directly on affected skin areas.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 2.8 g 6 g 74 g 73.7 g
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
24286-1574-01 24286-1574-1 Main listing 74 g in 1 TUBE 2019-08-26 — Active
24286-1574-02 You're viewing this 156 g in 1 JAR 2019-08-26 — Active
24286-1574-03 24286-1574-3 73.7 g in 1 JAR 2021-03-26 — Active
24286-1574-04 24286-1574-4 6 g in 1 JAR 2021-10-19 — Active
24286-1574-05 24286-1574-5 2.8 g in 1 POUCH 2019-08-26 — Active

Pack size FAQ

What quantity is in this package?
This package contains 156 g — 156 g in 1 jar.
How does this package differ from NDC 24286-1574-05?
Both are Acne Treatment with Sulfur 10 g/100g Ointment — the drug itself is identical. This page's package is the 156 g one, while NDC 24286-1574-05 is the 2.8 g package.
What NDC number is used to bill for this package of Acne Treatment with Sulfur 10 g/100g Ointment?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Acne Treatment with Sulfur 10 g/100gthis 24286-1574-02 DLC 156 g — — FDA listed —
Earths Care Acne Spot Treatment 10 g/100g 24286-1557-01 DLC 1 tube — — FDA listed —
Detoxify Facial Mask 10 g/100g 72957-0007-01 Private 85 g — — FDA listed —
Sulfur Calming Mask 10 g/100g 70764-0103-52 CONTROL 1 jar — — FDA listed —
Dermaharmony 10% Sulfur 10 g/100g 71819-0014-04 D3 113 g — — FDA listed —
Anti Acne Natural Volcanic Sulfur 10 g/100g 26050-0101-01 PT. 100 g — — FDA listed —
Dermaharmony 10% Sulfur with Tea Tree Oil 10 g/100g 71819-0015-04 D3 113 g — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2019
On the market since
Aug 2019
📍
2026
Currently FDA-listed
7 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color yellow
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 3WJQ0SDW1A
    Polyethylene glycol is a synthetic liquid or solid polymer used in medicines as a solvent, lubricant, and humectant. It helps dissolve active ingredients, reduces friction during manufacturing, and retains moisture in the final product.

1 inactive ingredient listed in the exact product block matched to this NDC.

The official label also statespolyethylene glycol

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerDLC Laboratories, Inc.
FDA applicationM006 (OTC MONOGRAPH DRUG)
Labeler code24286
First marketedAug 2019
Product typeHuman Otc Drug
Portfolio29 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 27 words ▾

Uses for the treatment of acne penetrates the pores and dries and clears acne pimples and blackheads helps to keep new acne pimples and blackheads from forming

⏱️ Dosage and Administration 71 words ▾

Directions cleanse the skin thoroughly before applying cover the entire affected area with a thin layer leave on for 10 minutes thoroughly remove with water because excessive drying of the skin may occur, start with one application daily, then gradually increase to two to three times daily if needed or as directed by a doctor if bothersome dryness or peeling occurs, reduce application to once a day or every other day

⚠️ Warnings 103 words ▾

Warnings For external use only Do not use on broken skin large areas of the skin When using this product do not get into eyes skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time or right after use of this product. If irritation occurs, only use one topical acne medication at a time. apply only to areas with acne Stop use and consult a doctor if excessive skin irritation develops or increases. Keep out of the reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 4 words ▾

Active ingredient Sulfur, 10%

🧪 Inactive Ingredients 4 words ▾

Inactive ingredient polyethylene glycol

🎯 Purpose 3 words ▾

Purpose Acne medication

📄 Do Not Use 11 words ▾

Do not use on broken skin large areas of the skin

📄 When Using This Product 54 words ▾

When using this product do not get into eyes skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time or right after use of this product. If irritation occurs, only use one topical acne medication at a time. apply only to areas with acne

📄 Stop Use and Ask a Doctor If 13 words ▾

Stop use and consult a doctor if excessive skin irritation develops or increases.

📄 Keep Out of Reach of Children 20 words ▾

Keep out of the reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📄 Questions or Comments 2 words ▾

Questions 1-800-858-3889

📄 Package Label / Principal Display Panel 36 words ▾

PRINCIPAL DISPLAY PANEL - 73.7 g Jar Label De La Cruz ® MAXIMUM STRENGTH ACNE TREATMENT With 10% Sulfur Tratamineot para el Acne- 10% Azufre Ointment- Pomada NET WT/ PESO NETO

2.6OZ (73.7 g) label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by DLC Laboratories, Inc.. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 4 other package presentations of this same product, including 2.8 g (24286-1574-05), 6 g (24286-1574-04), 74 g (24286-1574-01). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
DLC Laboratories, Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 24286-1573-01 · DLC 24286-1576-08 · DLC →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.